Optetrak
Payments companies reported to CMS as associated with Optetrak. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Optetrak, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Optetrak
These are the largest totals companies reported as associated with Optetrak. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Bernard Stulberg | Solon, OH | Orthopaedic Surgery | $98,746.86 |
| David Covall | Cumming, GA | Orthopaedic Surgery | $73,942.51 |
| Kyle Swanson | Mankato, MN | Orthopaedic Surgery | $66,222.45 |
| Jay Mabrey | Dallas, TX | Orthopaedic Surgery | $61,156.30 |
| Daniel Allison | Los Angeles, CA | Orthopaedic Surgery | $36,871.12 |
| James Huddleston | Stanford, CA | Adult Reconstructive Orthopaedic Surgery | $12,115.86 |
Prescribed Optetrak?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.